741 related articles for article (PubMed ID: 32718895)
21. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
22. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
23. Surviving COVID-19: A disease tolerance perspective.
Ayres JS
Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
[No Abstract] [Full Text] [Related]
24. SARS-CoV-2 vaccination-A plea for fast and coordinated action.
Beer M; Doherr M; Osterrieder K; Pfeiffer D; Trimpert J
Zoonoses Public Health; 2020 Nov; 67(7):840. PubMed ID: 32609415
[No Abstract] [Full Text] [Related]
25. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
Dong H
Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
[No Abstract] [Full Text] [Related]
26. Optimizing safety surveillance for COVID-19 vaccines.
Chandler RE
Nat Rev Immunol; 2020 Aug; 20(8):451-452. PubMed ID: 32555401
[TBL] [Abstract][Full Text] [Related]
27. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.
Mellors J; Tipton T; Longet S; Carroll M
Front Immunol; 2020; 11():1450. PubMed ID: 32733480
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 shot protects monkeys.
Cohen J
Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
[No Abstract] [Full Text] [Related]
29. Immune-mediated approaches against COVID-19.
Florindo HF; Kleiner R; Vaskovich-Koubi D; Acúrcio RC; Carreira B; Yeini E; Tiram G; Liubomirski Y; Satchi-Fainaro R
Nat Nanotechnol; 2020 Aug; 15(8):630-645. PubMed ID: 32661375
[TBL] [Abstract][Full Text] [Related]
30. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
Lindholm PF; Ramsey G; Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
[TBL] [Abstract][Full Text] [Related]
31. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
Poulas K; Farsalinos K; Zanidis C
Front Immunol; 2020; 11():1373. PubMed ID: 32612613
[No Abstract] [Full Text] [Related]
32. [Adaptive immunity against SARS-CoV-2].
Combadière B
Med Sci (Paris); 2020 Oct; 36(10):908-913. PubMed ID: 32960167
[TBL] [Abstract][Full Text] [Related]
33. T cells found in coronavirus patients 'bode well' for long-term immunity.
Leslie M
Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
[No Abstract] [Full Text] [Related]
34. The false promise of herd immunity for COVID-19.
Aschwanden C
Nature; 2020 Nov; 587(7832):26-28. PubMed ID: 33087872
[No Abstract] [Full Text] [Related]
35. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
36. COVID-19 vaccine design: the Janus face of immune enhancement.
Hotez PJ; Corry DB; Bottazzi ME
Nat Rev Immunol; 2020 Jun; 20(6):347-348. PubMed ID: 32346094
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2: A New Song Recalls an Old Melody.
Subbarao K
Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccines: Knowing the unknown.
Lv H; Wu NC; Mok CKP
Eur J Immunol; 2020 Jul; 50(7):939-943. PubMed ID: 32437587
[TBL] [Abstract][Full Text] [Related]
39. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
40. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
